MULTI EXPRESS DEFENDER VONCERT - MULTI UNDERLYINGS | Market Closed - Borsa Italiana 16:44:59 29/04/2024 BST | ||
| 32.5 EUR | 0.00% |
|
| Current month | -17.09% | ||
| 1 month | -17.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 32.5 | -0.61% | 12 |
| 26/04/24 | 32.7 | +1.24% | 25 |
| 25/04/24 | 32.3 | 0.00% | 17 |
| 24/04/24 | 32.3 | -3.87% | 18 |
| 23/04/24 | 33.6 | +0.90% | 30 |
Real-time Borsa Italiana
Last update April 29, 2024 at 04:44 pm
More quotesStatic data
| Product type | Certificati Altri |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| F14313 | |
| ISIN | DE000VQ8PSL4 |
| Date issued | 18/06/2021 |
| Maturity | 17/06/2024 (49 Days) |
| Parity | 2.43 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 98.7 € |
|---|---|
| Lowest since issue | 31.7 € |
| Spread | 0.8 € |
| Spread % | 2.43% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
276.4
USD
Average target price
303.3
USD
Spread / Average Target
+9.72%
- Stock Market
- Certificates
- F14313 Certificat
